相关实验视频

Updated: Jul 18, 2026

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.4K

使用氨基酸类型标签对原发性癌细胞分泌物的评估

Annemieke C Bouwman1, Antoinette van Weverwijk2, Onno B Bleijerveld3

  • 1Division of Tumor Biology & Immunology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Immunology, Leiden University Medical Centre, Leiden, The Netherlands.

Methods in cell biology
|July 19, 2025
PubMed
概括

这项研究提出了一种绘制癌细胞分泌物的新方法,识别癌细胞分泌的蛋白质. 这种方法有助于理解瘤微环境的沟通,并发现新的治疗点.

关键词:
氨基酸标记的标签癌细胞的分泌体是癌细胞的分泌体.癌症 - 免疫性交叉通话细胞与细胞的相互作用.质谱法质谱法质谱法瘤微环境是一个微环境.

更多相关视频

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

12.3K
"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome06:31

"Cell Surface Capture" Workflow for Label-Free Quantification of the Cell Surface Proteome

Published on: March 24, 2023

2.5K

相关概念视频

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...